Concurrent Hyperfractionated Chemoradiation Versus Conventional Fractionated Chemoradiation with Low-dose Weekly Paclitaxel in Locally Advanced Non–Small-Cell Lung Cancer in a Tertiary Cancer Center in Kashmir: A Prospective Study
Journal Title: INTERNATIONAL JOURNAL OF SCIENTIFIC STUDY - Year 2019, Vol 6, Issue 11
Abstract
Introduction: Lung cancer is the most common cancer worldwide and has a poor prognosis but integration of chemoradiation has led to an increase in overall survival time and percentage of cured patients with acceptable toxicity. Purpose: The purpose of this study was to compare the efficacy of hyperfractionated (HFX) radiotherapy with conventional radiotherapy and weekly concurrent paclitaxel in stage IIB/III non-small-cell lung cancer (NSCLC). Materials and Methods: A total of 60 patients were enrolled, of which 30 patients were given twice daily radiotherapy (1.2 Gy each) to a total of 72 Gy over 5–6 weeks and 30 patients were given single daily fraction (2 Gy) to a total of 66 Gy for the same duration to achieve a comparable biological effective dose. Both groups received weekly 50 mg/m2 paclitaxel. Results: An overall response of 83.3% versus 56.6% with a partial response of 70% versus 53.3% and complete response (CR) of 13.3% versus 3% was seen in HFX radiotherapy versus conventional radiotherapy which was statistically significant (P = 0.04). 10 of 25 patients and 11 of 17 patients who achieved response in study and control groups, respectively, progressed. The median survival of patients in HFX radiotherapy arm was 18 months, compared to 9 months in conventional radiotherapy arm. The median time to local recurrence was 19 versus 11 months with local recurrence-free survival of 72% versus 66% at 1 year follow-up. The 1 and 2 year survival rates were 76% and 40% in study arm and 50% and 26% in control arm (P - 0.005). Esophagitis (70% vs. 63.3%), skin reaction (70% vs. 63.3%), and radiation-induced pneumonitis (50% vs. 43.3%) were the common toxicities with no statistical significance between the two groups. Overall, there was mild chemotherapy-related toxicity. Conclusions: The combination of HFX radiation with weekly paclitaxel is effective treatment with a moderate degree of toxicity in stage IIB/III NSCLC. An average response to treatment and the use of lesser drugs have made us to consider this therapy in locally advanced NSCLC.
Authors and Affiliations
Wani Y Nahida, Subiya Kaneez, Bhat Tanveer, Mohd Ashraf, Muhib Ul Haq, Abdul Majeed, Sanaullah Kuchay
Perception of Anesthesiology Students of Zahedan University of Medical Sciences from Clinical Learning Environment
Introduction: An appropriate learning environment is crucial for delivering quality education. Students’ expectations from the clinical learning environment differ from the real environment. The purpose of this study is...
Comparison of Outcomes between Video-assisted Thoracoscopic Surgery and Thoracotomy in Pediatric Patients for Empyema
Introduction: A thoracotomy is a major surgical procedure that allows surgeons to access the lungs, heart, aorta, and diaphragm during surgery. The open surgical procedure, performed under general anesthesia, is performe...
Clinical Profile of Diabetic Foot Infections
Background: Diabetic foot infections (DFIs) are associated with substantial morbidity and mortality. Patients with a DFI should be evaluated comprehensively, and employing multidisciplinary foot teams improve outcomes. A...
Association of Impacted Third Molars with Facial Growth Patterns among Adult Indian Patients - A Retrospective Study
Introduction: The third molar (3M) varies more than other molars in terms of shape, size, timing of eruption, and tendency toward impaction. Hence, studies need to be carried out to clarify the association of the various...
Clinical Study of Foreign Body in Aerodigestive Tract
Aim: The present study of foreign bodies in aerodigestive tract was undertaken to study the various parameters basis of history, examination, and investigations. Materials and Methods: A total of 72 cases of foreign bodi...